Question 1

Does Connor, Clark & Lunn Investment Management own ETON stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Connor, Clark & Lunn Investment Management holds 13,150 shares of ETON (Eton Pharmaceuticals), worth $476,030.

Question 2

How many shares of ETON does Connor, Clark & Lunn Investment Management own?

Accepted Answer

As of its Q2 2026 13F, Connor, Clark & Lunn Investment Management holds 13,150 shares of ETON (Eton Pharmaceuticals).

Question 3

What is Connor, Clark & Lunn Investment Management's ETON position worth?

Accepted Answer

As of its Q2 2026 13F, Connor, Clark & Lunn Investment Management's ETON position is worth $476,030.

Question 4

Is Connor, Clark & Lunn Investment Management buying or selling ETON?

Accepted Answer

In Q2 2026, Connor, Clark & Lunn Investment Management reduced its ETON position by 29,543 shares (-69.2%).

Question 5

When did Connor, Clark & Lunn Investment Management first buy ETON?

Accepted Answer

Connor, Clark & Lunn Investment Management first reported ETON in its Q3 2023 13F and has listed it in 12 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	13,150	-69.2%	$476,030	0.0%	$36.20	0
2026-Q1	Decreased	42,693	-44.3%	$1.1M	0.0%	$24.68	0
2025-Q4	Decreased	76,586	-46.8%	$1.3M	0.0%	$16.91	0
2025-Q3	Decreased	143,811	-35.2%	$3.1M	0.0%	$21.73	0
2025-Q2	Decreased	222,083	-4.5%	$3.2M	0.0%	$14.25	0
2025-Q1	Increased	232,532	+8.2%	$3M	0.0%	$12.98	29
2024-Q4	Increased	214,878	+230.5%	$2.9M	0.0%	$13.32	42
2024-Q3	Increased	65,014	+86.6%	$390,084	0.0%	$6.00	37